Table 1. Serum HYA Levels in Subgroups... | American Society of Hematology

Table 1.

Serum HYA Levels in Subgroups of Myeloma Patients

	N	%	Serum Hyaluronan Level						Total %
			0-9 μg/L		10-120 μg/L		>120 μg/L
			N	%	N	%	N	%
Stage
I	34	9	0	0	32	94	2	6	100
II	130	34	6	5	106	82	18	14	100
III	222	57	14	6	177	80	31	14	100
Total	386	100
M-comp Ig class^*
IgA	82	21	10	12	67	82	5	6	100
IgG	224	59	9	4	186	83	29	13	100
BJ^†	76	20	1	1	59	78	16	21	100
Total	382	100

	N	%	Serum Hyaluronan Level						Total %
			0-9 μg/L		10-120 μg/L		>120 μg/L
			N	%	N	%	N	%
Stage
I	34	9	0	0	32	94	2	6	100
II	130	34	6	5	106	82	18	14	100
III	222	57	14	6	177	80	31	14	100
Total	386	100
M-comp Ig class^*
IgA	82	21	10	12	67	82	5	6	100
IgG	224	59	9	4	186	83	29	13	100
BJ^†	76	20	1	1	59	78	16	21	100
Total	382	100

Number and percentage of myeloma patients in different disease stages (upper part) and with different M-component Ig classes (lower part) are given to the left. To the right individuals in the various stages (upper part) and with various M-component Ig classes (lower part) are separated according to abnormally low, intermediate, and high serum HYA levels.

Three cases with IgD and one nonsecretory case are excluded.

†

Bence Jones protein.

View Large

This Feature Is Available To Subscribers Only